oxymatrine has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, Y; Lin, Z; Luo, R; Shao, J; Xie, L | 1 |
| Chen, XW; Dong, P; Jin, B; Xie, J; Xu, HM; Ying, XJ | 1 |
2 other study(ies) available for oxymatrine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m
Topics: Alkaloids; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Methyltransferases; Mouth Neoplasms; Quinolizines; Receptors, CXCR4; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck | 2022 |
Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro.
Topics: Alkaloids; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Knockdown Techniques; Humans; Laryngeal Neoplasms; Papillomavirus E7 Proteins; Quinolizines; RNA, Messenger | 2015 |